• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Ossio closes $38.5M Series C

Ossio closes $38.5M Series C

October 17, 2022 By Sean Whooley

OssioOrthopedic fixation technology developer Ossio announced today that it closed a $38.5 million Series C financing round.

Growth equity firm MVM Partners led the funding. Current shareholders also participated in the round.

“We are delighted to have secured this level of interest and commitment from such an experienced and distinguished medical technology investment firm,” said Ossio CEO Brian Verrier. “The additional funding will enable us to accelerate further adoption of Ossiofiber intelligent bone regeneration technology by orthopedic and podiatric surgeons in the United States.

“Specifically, we intend to use these funds to fortify new product development, sales force expansion, patient outreach and medical education.”

Woburn, Massachusetts-based Ossio develops implants with its Ossiofiber intelligent bone regeneration technology. The company designed it to solve the shortcomings of permanent metal hardware and conventional, resorbable and allograft implants.

The technology combines mechanical strength and natural bone healing in a non-permanent implant. It is comprised of a proprietary mineral fiber matrix held together by a naturally degradable polymer. Ossio designed it with bio-integrative material properties that provide surgeons with a more biologically friendly way to restore patient stability and mobility while leaving nothing permanent behind.

Ossio developed its technology for rapid bone in-growth, regeneration and replacement. The company said orthopedic surgeons implanted more than 10,000 Ossiofiber implants since its introduction in 2019.

In connection with the financing, MVM’s Dr. Stephen Reeders and Dr. Kevin Cheng joined Ossio’s board of directors.

“We believe that Ossio’s novel bio-integrative technology has the potential to transform the orthopedic fixation market,” said Reeders. “We are excited to support the company’s mission to improve patient outcomes across a broad range of procedures.”

Filed Under: Business/Financial News, Funding Roundup, Orthopedics Tagged With: ossio

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy